Tobias Borchert1, Laura Beitar1, Laura B N Langer1, Andras Polyak1, Hans-Jürgen Wester2, Tobias L Ross1, Denise Hilfiker-Kleiner3, Frank M Bengel1, James T Thackeray4. 1. Department of Nuclear Medicine, Hannover Medical School, Carl Neuberg-Str. 1, 30625, Hannover, Germany. 2. Department of Radiopharmaceutical Chemistry, Technical University of Munich, Munich, Germany. 3. Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany. 4. Department of Nuclear Medicine, Hannover Medical School, Carl Neuberg-Str. 1, 30625, Hannover, Germany. Thackeray.James@mh-hannover.de.
Abstract
BACKGROUND: Leukocyte subtypes bear distinct pro-inflammatory, reparative, and regulatory functions. Imaging inflammation provides information on disease prognosis and may guide therapy, but the cellular basis of the signal remains equivocal. We evaluated leukocyte subtype specificity of characterized clinically relevant inflammation-targeted radiotracers. METHODS AND RESULTS: Leukocyte populations were purified from blood- and THP-1-derived macrophages were polarized into M1-, reparative M2a-, or M2c-macrophages. In vitro uptake assays were conducted using tracers of enhanced glucose or amino acid metabolism and molecular markers of inflammatory cells. Both 18F-deoxyglucose (18F-FDG) and the labeled amino acid 11C-methionine (11C-MET) displayed higher uptake in neutrophils and monocytes compared to other leukocytes (P = 0.005), and markedly higher accumulation in pro-inflammatory M1-macrophages compared to reparative M2a-macrophages (P < 0.001). Molecular tracers 68Ga-DOTATATE targeting the somatostatin receptor type 2 and 68Ga-pentixafor targeting the chemokine receptor type 4 (CXCR4) exhibited broad uptake by leukocyte subpopulations and polarized macrophages with highest uptake in T-cells/natural killer cells and B-cells compared to neutrophils. Mitochondrial translocator protein (TSPO)-targeted 18F-flutriciclamide selectively accumulated in monocytes and pro-inflammatory M1 macrophages (P < 0.001). Uptake by myocytes and fibroblasts tended to be higher for metabolic radiotracers. CONCLUSIONS: The different in vitro cellular uptake profiles may allow isolation of distinct phases of the inflammatory pathway with specific inflammation-targeted radiotracers. The pathogenetic cell population in specific inflammatory diseases should be considered in the selection of an appropriate imaging agent.
BACKGROUND: Leukocyte subtypes bear distinct pro-inflammatory, reparative, and regulatory functions. Imaging inflammation provides information on disease prognosis and may guide therapy, but the cellular basis of the signal remains equivocal. We evaluated leukocyte subtype specificity of characterized clinically relevant inflammation-targeted radiotracers. METHODS AND RESULTS: Leukocyte populations were purified from blood- and THP-1-derived macrophages were polarized into M1-, reparative M2a-, or M2c-macrophages. In vitro uptake assays were conducted using tracers of enhanced glucose or amino acid metabolism and molecular markers of inflammatory cells. Both 18F-deoxyglucose (18F-FDG) and the labeled amino acid 11C-methionine (11C-MET) displayed higher uptake in neutrophils and monocytes compared to other leukocytes (P = 0.005), and markedly higher accumulation in pro-inflammatory M1-macrophages compared to reparative M2a-macrophages (P < 0.001). Molecular tracers 68Ga-DOTATATE targeting the somatostatin receptor type 2 and 68Ga-pentixafor targeting the chemokine receptor type 4 (CXCR4) exhibited broad uptake by leukocyte subpopulations and polarized macrophages with highest uptake in T-cells/natural killer cells and B-cells compared to neutrophils. Mitochondrial translocator protein (TSPO)-targeted 18F-flutriciclamide selectively accumulated in monocytes and pro-inflammatory M1 macrophages (P < 0.001). Uptake by myocytes and fibroblasts tended to be higher for metabolic radiotracers. CONCLUSIONS: The different in vitro cellular uptake profiles may allow isolation of distinct phases of the inflammatory pathway with specific inflammation-targeted radiotracers. The pathogenetic cell population in specific inflammatory diseases should be considered in the selection of an appropriate imaging agent.
Authors: Christoph Rischpler; Ralf J Dirschinger; Stephan G Nekolla; Hans Kossmann; Stefania Nicolosi; Franziska Hanus; Sandra van Marwick; Karl P Kunze; Alexander Meinicke; Katharina Götze; Adnan Kastrati; Nicolas Langwieser; Tareq Ibrahim; Matthias Nahrendorf; Markus Schwaiger; Karl-Ludwig Laugwitz Journal: Circ Cardiovasc Imaging Date: 2016-04 Impact factor: 7.792
Authors: Hendrik B Sager; Maarten Hulsmans; Kory J Lavine; Marina B Moreira; Timo Heidt; Gabriel Courties; Yuan Sun; Yoshiko Iwamoto; Benoit Tricot; Omar F Khan; James E Dahlman; Anna Borodovsky; Kevin Fitzgerald; Daniel G Anderson; Ralph Weissleder; Peter Libby; Filip K Swirski; Matthias Nahrendorf Journal: Circ Res Date: 2016-07-21 Impact factor: 17.367
Authors: P K Shah; E Falk; J J Badimon; A Fernandez-Ortiz; A Mailhac; G Villareal-Levy; J T Fallon; J Regnstrom; V Fuster Journal: Circulation Date: 1995-09-15 Impact factor: 29.690
Authors: Nele Hermanns; Viola Wroblewski; Pablo Bascuñana; Bettina Wolf; Andras Polyak; Tobias L Ross; Frank M Bengel; James T Thackeray Journal: Basic Res Cardiol Date: 2022-10-24 Impact factor: 12.416
Authors: Tobias Borchert; Annika Hess; Mario Lukačević; Tobias L Ross; Frank M Bengel; James T Thackeray Journal: Eur J Nucl Med Mol Imaging Date: 2020-03-03 Impact factor: 9.236
Authors: Eric J Meester; Erik de Blois; Boudewijn J Krenning; Antonius F W van der Steen; Jeff P Norenberg; Kim van Gaalen; Monique R Bernsen; Marion de Jong; Kim van der Heiden Journal: EJNMMI Res Date: 2021-03-17 Impact factor: 3.138
Authors: Andrej Ćorović; Christopher Wall; Justin C Mason; James H F Rudd; Jason M Tarkin Journal: Curr Cardiol Rep Date: 2020-08-09 Impact factor: 3.955